News
Kidneys play a vital role in filtering blood and maintaining bodily balance. However, kidney disease affects millions, often ...
For the more than half a million Americans receiving dialysis, treatment doesn't end when they leave the center. Many patients manage complex medication regimens at home, often taking more than 10 ...
Kidney disease is devastating Black communities—and the crisis is deepening. While over 1 in 7 U.S. adults lives ...
Analysts have recently evaluated Ardelyx and provided 12-month price targets. The average target is $11.25, accompanied by a ...
IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million Company ends Q2 with $238.5 million in cash, cash equivalents and investments Company raises ...
Addressing the complex health needs of people with chronic conditions requires innovative solutions and strong collaborative efforts.
One of the most common skin problems for people with chronic kidney disease, especially those in later stages or on dialysis, ...
4d
Stocktwits on MSNArdelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions ComingShares of Ardelyx Inc. (ARDX) jumped 16% higher on Tuesday morning after multiple brokerages upped their price targets on the ...
We need phosphorus to grow our food, but we're running out. We've known for 100 years that depletion is imminent. Now is the time for us to invest and diversify sources.
Wells (@dwallacewells), a writer for Opinion and a columnist for The New York Times Magazine, is the author of “The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results